medline ipo, medline inc, medline valuation, medline share price, medline initial public offering

Medline — the U.S. medical‑supply titan — is officially gearing up for one of the biggest IPOs of 2025, targeting a jaw‑dropping $55.3 billion valuation.
The Illinois-based giant plans to raise up to $5.37 billion by offering 179 million shares priced between $26–$30 each.

This blockbuster IPO lands right as the U.S. IPO market heats up again, with companies rushing to go public before the holiday slowdown. Analysts say Medline’s offering could become THE defining IPO of Q4 2025, signaling strong investor appetite returning to the healthcare sector.

Why Medline’s IPO Matters: The Healthcare Giant Behind America’s Supplies

Medline is not a typical manufacturer — it’s one of the largest privately-held medical supply companies in the world. Hospitals, clinics, pharmacies, and surgical centers rely on Medline’s products every single day.

The company’s scale, distribution network, and financial stability position it as a heavyweight IPO contender, drawing massive interest from:

• Institutional investors
• Healthcare-focused funds
• Private‑equity groups
• Global asset managers

Cornerstone investors are already lined up to purchase up to $2.35 billion worth of shares — a powerful early signal of market confidence.

The Mills Family: Multi‑Billion Fortune Behind Medline

Secondary Keywords: medline founding family, mills family net worth, medline ipo stakeholders

While Medline sold a majority stake to private equity in 2021, the founding Mills family still holds a massive position.

According to Forbes, their remaining stake in Medline’s IPO could exceed $6 billion, raising their combined estimated net worth to $20+ billion.

This IPO not only highlights Medline’s strength — it also showcases one of America’s most successful family-built empires.

What the Medline IPO Means for the Market

With the offering expected to be 2025’s largest, analysts predict:

• A surge of institutional inflow into healthcare stocks
• Renewed confidence in late-year IPO activity
• A benchmark valuation for other medical supply companies
• Strong demand due to recession‑resistant industry fundamentals

If priced at the upper range, Medline becomes one of the most valuable healthcare IPOs in U.S. history.

Key IPO Highlights

• Valuation Target: Up to $55.3 billion
• Funds to Raise: Up to $5.37 billion
• Share Price Range: $26–$30
• Shares Offered: 179 million
• Cornerstone Investors: Up to $2.35 billion committed
• Industry: Medical supplies & healthcare distribution
• Expected Impact: One of 2025’s biggest IPO market events

medline ipo, medline inc, medline ipo news, medline valuation, medline share price, medline stock, medline ipo date, medline mills family, medline investor details, medline initial public offering, 2025 ipo market, healthcare ipo, medical supply company ipo, stock market news, wall street ipo